This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Bagot CN, Arya R (2008) Virchow and his triad: a question of attribution. Br J Haematol 143:180–190. doi: 10.1111/j.1365-2141.2008.07323.x.BagotCNAryaR2008Virchow and his triad: a question of attribution14318019010.1111/j.1365-2141.2008.07323.xOpen DOISearch in Google Scholar
Battistini B (2003) Modulation and roles of the endothelins in the pathophysiology of pulmonary embolism. Can J Physiol Pharmacol 81:555–569. doi: 10.1139/y03-017BattistiniB2003Modulation and roles of the endothelins in the pathophysiology of pulmonary embolism8155556910.1139/y03-017Open DOISearch in Google Scholar
Becattini C, Agnelli G, Prandoni P et al (2005) A prospective study on cardiovascular events after acute pulmonary embolism. Eur Heart J 26:77–83. doi: 10.1093/eurheartj/ehi018BecattiniCAgnelliGPrandoniP2005A prospective study on cardiovascular events after acute pulmonary embolism26778310.1093/eurheartj/ehi018Open DOISearch in Google Scholar
Bergami M, Cenko E, Yoon J et al (2022) Statins for primary prevention among elderly men and women. Cardiovasc Res 118:3000–3009. doi: 10.1093/cvr/cvab348BergamiMCenkoEYoonJ2022Statins for primary prevention among elderly men and women1183000300910.1093/cvr/cvab348Open DOISearch in Google Scholar
Biere-Rafi S, Hutten BA, Squizzato A et al (2013) Statin treatment and the risk of recurrent pulmonary embolism. Eur Heart J 34:1800–1806. doi: 10.1093/eurheartj/eht046Biere-RafiSHuttenBASquizzatoA2013Statin treatment and the risk of recurrent pulmonary embolism341800180610.1093/eurheartj/eht046Open DOISearch in Google Scholar
Bova C, Marchiori A, Noto A et al (2006) Incidence of arterial cardiovascular events in patients with idiopathic venous thromboembolism. A retrospective cohort study. Thromb Haemost 96:132–136.BovaCMarchioriANotoA2006Incidence of arterial cardiovascular events in patients with idiopathic venous thromboembolism. A retrospective cohort study96132136Search in Google Scholar
Brauninge H, B. Stoffers B, Fitzek ADE et al (2022) Cardiac SARS-CoV-2 infection is associated with pro-inflammatory transcriptomic alterations within the heart. Cardiovasc Res 118:542–555. doi: 10.1093/cvr/cvab322BrauningeHB. StoffersBFitzekADE2022Cardiac SARS-CoV-2 infection is associated with pro-inflammatory transcriptomic alterations within the heart11854255510.1093/cvr/cvab322Open DOISearch in Google Scholar
Colotta F, Sciacca FL, Sironi M et al (1994) Expression of monocyte chemotactic protein-1 by monocytes and endothelial cells exposed to thrombin. Am J Pathol 144:975–985.ColottaFSciaccaFLSironiM1994Expression of monocyte chemotactic protein-1 by monocytes and endothelial cells exposed to thrombin144975985Search in Google Scholar
Conti P, Pang X, Boucher W et al (1997) Monocyte chemotactic protein-1 is a proinflammatory chemokine in rat skin injection sites and chemoattracts basophilic granular cells. Int Immunol 9:1563–1570. doi: 10.1093/intimm/9.10.1563ContiPPangXBoucherW1997Monocyte chemotactic protein-1 is a proinflammatory chemokine in rat skin injection sites and chemoattracts basophilic granular cells91563157010.1093/intimm/9.10.1563Open DOISearch in Google Scholar
Coughlin SR (2000) Thrombin signalling and protease-activated receptors. Nature 407:258–264. doi: 10.1038/35025229CoughlinSR2000Thrombin signalling and protease-activated receptors40725826410.1038/35025229Open DOISearch in Google Scholar
Dias-Junior CA, Cau SB, Oliveira AM et al (2009) Nitrite or sildenafil, but not BAY 41-2272, blunt acute pulmonary embolism-induced increases in circulating matrix metalloproteinase-9 and oxidative stress. Thromb Res 124:349–355.Dias-JuniorCACauSBOliveiraAM2009Nitrite or sildenafil, but not BAY 41-2272, blunt acute pulmonary embolism-induced increases in circulating matrix metalloproteinase-9 and oxidative stress124349355Search in Google Scholar
Ding WY, Protty MB, Davies IG et al (2022) Relationship between lipoproteins, thrombosis, and atrial fibrillation. Cardiovasc Res 118:716–731. doi: 10.1093/cvr/cvab017DingWYProttyMBDaviesIG2022Relationship between lipoproteins, thrombosis, and atrial fibrillation11871673110.1093/cvr/cvab017Open DOISearch in Google Scholar
Dittmeier M, Kraft P, Schuhmann MK et al (2016) Pretreatment with rivaroxaban attenuates stroke severity in rats by a dual antithrombotic and anti-inflammatory mechanism. Thromb Haemost 115:835–843. doi: 10.1160/TH15-08-0631DittmeierMKraftPSchuhmannMK2016Pretreatment with rivaroxaban attenuates stroke severity in rats by a dual antithrombotic and anti-inflammatory mechanism11583584310.1160/TH15-08-0631Open DOISearch in Google Scholar
Doggen CJ, Lemaitre RN, Smith NL et al (2004) HMG CoA reductase inhibitors and the risk of venous thrombosis among postmenopausal women. J Thromb Haemost 2:700–701. doi: 10.1111/j.1538-7836.2004.00696.DoggenCJLemaitreRNSmithNL2004HMG CoA reductase inhibitors and the risk of venous thrombosis among postmenopausal women270070110.1111/j.1538-7836.2004.00696Open DOISearch in Google Scholar
Dolci DT, Fuentes CB, Rolim D et al (2010) Time course of haemo-dynamic, respiratory and inflammatory disturbances induced by experimental acute pulmonary polystyrene microembolism. Eur J Anaesthesiol 27:67–76. doi: 10.1097/EJA.0b013e32832bfd7eDolciDTFuentesCBRolimD2010Time course of haemo-dynamic, respiratory and inflammatory disturbances induced by experimental acute pulmonary polystyrene microembolism27677610.1097/EJA.0b013e32832bfd7eOpen DOISearch in Google Scholar
Downing LJ, Strieter RM, Kadell AM et al (1996) Neutrophils are the initial cell type identified in deep venous thrombosis induced vein wall inflammation. ASAIO J 42:M677–682. doi: 10.1097/00002480-199609000-00073DowningLJStrieterRMKadellAM1996Neutrophils are the initial cell type identified in deep venous thrombosis induced vein wall inflammation42M67768210.1097/00002480-199609000-00073Open DOISearch in Google Scholar
Downing LJ, Wakefield TW, Strieter RM et al (1997) Anti-P-select in antibody decreases inflammation and thrombus formation in venous thrombosis. J Vasc Surg 25:816–827; discussion 828. doi: 10.1016/s0741-5214(97)70211-8.DowningLJWakefieldTWStrieterRM1997Anti-P-select in antibody decreases inflammation and thrombus formation in venous thrombosis25816827discussion 828.10.1016/s0741-5214(97)70211-8Open DOISearch in Google Scholar
Eagleton MJ, Henke PK, Luke CE et al (2002) Southern Association for Vascular Surgery William J. von Leibig Award. Inflammation and intimal hyperplasia associated with experimental pulmonary embolism. J Vasc Surg 36:581–588. doi: 10.1067/mva.2002.126556EagletonMJHenkePKLukeCE2002Southern Association for Vascular Surgery William J. von Leibig Award. Inflammation and intimal hyperplasia associated with experimental pulmonary embolism3658158810.1067/mva.2002.126556Open DOISearch in Google Scholar
Ellinghaus P, Perzborn E, Hauenschild P et al (2016) Expression of pro-inflammatory genes in human endothelial cells: Comparison of rivaroxaban and dabigatran. Thromb Res 142:44–51. doi: 10.1016/j.thromres.2016.04.008EllinghausPPerzbornEHauenschildP2016Expression of pro-inflammatory genes in human endothelial cells: Comparison of rivaroxaban and dabigatran142445110.1016/j.thromres.2016.04.008Open DOISearch in Google Scholar
Feng Y, Zhang F, Niu L et al (2016) Simvastatin ameliorates deep vein thrombosis in rabbits by regulating the fibrinolytic system. Blood Coagul Fibrinolysis 27:531–541. doi: 10.1097/MBC.0000000000000567FengYZhangFNiuL2016Simvastatin ameliorates deep vein thrombosis in rabbits by regulating the fibrinolytic system2753154110.1097/MBC.0000000000000567Open DOISearch in Google Scholar
Fernandez-Patron C, Radomski MW, Davidge ST (1999) Vascular matrix metalloproteinase-2 cleaves big endothelin-1 yielding a novel vasoconstrictor. Circ Res 85:906–911. doi: 10.1161/01.res.85.10.90Fernandez-PatronCRadomskiMWDavidgeST1999Vascular matrix metalloproteinase-2 cleaves big endothelin-1 yielding a novel vasoconstrictor8590691110.1161/01.res.85.10.90Open DOISearch in Google Scholar
Fernandez-Patron C, Stewart KG, Zhang Y et al (2000) Vascular matrix metalloproteinase-2-dependent cleavage of calcitonin gene-related peptide promotes vasoconstriction. Circ Res 87:670–676. doi: 10.1161/01.res.87.8.670Fernandez-PatronCStewartKGZhangY2000Vascular matrix metalloproteinase-2-dependent cleavage of calcitonin gene-related peptide promotes vasoconstriction8767067610.1161/01.res.87.8.670Open DOISearch in Google Scholar
Galeano-Valle F, Ordieres-Ortega L, Oblitas CM et al (2021) Inflammatory biomarkers in the short-term prognosis of venous thromboembolism: A narrative review. Int J Mol Sci 2:2627. doi: 10.3390/ijms22052627Galeano-ValleFOrdieres-OrtegaLOblitasCM2021Inflammatory biomarkers in the short-term prognosis of venous thromboembolism: A narrative review2262710.3390/ijms22052627Open DOISearch in Google Scholar
Gibbs J, Ince L, Matthews L et al (2014) An epithelial circadian clock controls pulmonary inflammation and glucocorticoid action. Nat Med 20:919–926. doi: 10.1038/nm.3599GibbsJInceLMatthewsL2014An epithelial circadian clock controls pulmonary inflammation and glucocorticoid action2091992610.1038/nm.3599Open DOISearch in Google Scholar
Girotra S, Murarka S, Migrino RQ (2012) Plaque regression and improved clinical outcomes following statin treatment in atherosclerosis. Panminerva Med 54:71–81.GirotraSMurarkaSMigrinoRQ2012Plaque regression and improved clinical outcomes following statin treatment in atherosclerosis547181Search in Google Scholar
Glynn RJ, Danielson E, Fonseca FA et al (2009) A randomized trial of rosuvastatin in the prevention of venous thromboembolism. N Engl J Med 360:1851–1861. doi: 10.1056/NEJMoa0900241GlynnRJDanielsonEFonsecaFA2009A randomized trial of rosuvastatin in the prevention of venous thromboembolism3601851186110.1056/NEJMoa0900241Open DOISearch in Google Scholar
Griffith JW, Sokol CL, Luster AD (2014) Chemokines and chemokine receptors: positioning cells for host defense and immunity. Annu Rev Immunol 32:659–702. doi: 10.1146/annurev-immunol-032713-120145GriffithJWSokolCLLusterAD2014Chemokines and chemokine receptors: positioning cells for host defense and immunity3265970210.1146/annurev-immunol-032713-120145Open DOISearch in Google Scholar
Gromadzinski L, Paukszto L, Lepiarczyk E et al (2023) Pulmonary artery embolism: comprehensive transcriptomic analysis in understanding the pathogenic mechanisms of the disease. BMC Genomics 24:10. doi: 10.1186/s12864-023-09110-0.GromadzinskiLPauksztoLLepiarczykE2023Pulmonary artery embolism: comprehensive transcriptomic analysis in understanding the pathogenic mechanisms of the disease241010.1186/s12864-023-09110-0Open DOISearch in Google Scholar
Haddad F, Hunt SA, Rosenthal DN et al (2008) Right ventricular function in cardiovascular disease, part I: Anatomy, physiology, aging, and functional assessment of the right ventricle. Circulation 117:1436–1448. doi: 10.1161/CIRCULATIONAHA.107.653576HaddadFHuntSARosenthalDN2008Right ventricular function in cardiovascular disease, part I: Anatomy, physiology, aging, and functional assessment of the right ventricle1171436144810.1161/CIRCULATIONAHA.107.653576Open DOISearch in Google Scholar
Halici B, Sarinc Ulasli S, Gunay E et al (2014) Assessment of inflammatory biomarkers and oxidative stress in pulmonary thromboembolism: follow-up results. Inflammation 37:1186–1190. doi: 10.1007/s10753-014-9844-yHaliciBSarinc UlasliSGunayE2014Assessment of inflammatory biomarkers and oxidative stress in pulmonary thromboembolism: follow-up results371186119010.1007/s10753-014-9844-yOpen DOISearch in Google Scholar
Hara T, Fukuda D, Tanaka K et al (2015) Rivaroxaban, a novel oral anticoagulant, attenuates atherosclerotic plaque progression and destabilization in ApoE-deficient mice. Atherosclerosis 242:639–646. doi: 10.1016/j.atherosclerosis.2015.03.023HaraTFukudaDTanakaK2015Rivaroxaban, a novel oral anticoagulant, attenuates atherosclerotic plaque progression and destabilization in ApoE-deficient mice24263964610.1016/j.atherosclerosis.2015.03.023Open DOISearch in Google Scholar
Harjola VP, Mebazaa A, Celutkiene J et al (2016) Contemporary management of acute right ventricular failure: a statement from the Heart Failure Association and the Working Group on Pulmonary Circulation and Right Ventricular Function of the European Society of Cardiology. Eur J Heart Fail 18:226–241. doi: 10.1002/ejhf.478HarjolaVPMebazaaACelutkieneJ2016Contemporary management of acute right ventricular failure: a statement from the Heart Failure Association and the Working Group on Pulmonary Circulation and Right Ventricular Function of the European Society of Cardiology1822624110.1002/ejhf.478Open DOISearch in Google Scholar
Hettwer J, Hinterdobler J, Miritsch B et al (2022) Interleukin-1beta suppression dampens inflammatory leucocyte production and uptake in atherosclerosis. Cardiovasc Res 118:2778–2791. doi: 10.1093/cvr/cvab337HettwerJHinterdoblerJMiritschB2022Interleukin-1beta suppression dampens inflammatory leucocyte production and uptake in atherosclerosis1182778279110.1093/cvr/cvab337Open DOISearch in Google Scholar
Huisman MV, Barco S, Cannegieter SC et al (2018) Pulmonary embolism. Nat Rev Dis Primers 4:18028. doi: 10.1038/nrdp.2018.28HuismanMVBarcoSCannegieterSC2018Pulmonary embolism41802810.1038/nrdp.2018.28Open DOISearch in Google Scholar
Humphries J, McGuinness CL, Smith A et al (1999) Monocyte chemotactic protein-1 (MCP-1) accelerates the organization and resolution of venous thrombi. J Vasc Surg 30:894–899. doi: 10.1016/s0741-5214(99)70014-5HumphriesJMcGuinnessCLSmithA1999Monocyte chemotactic protein-1 (MCP-1) accelerates the organization and resolution of venous thrombi3089489910.1016/s0741-5214(99)70014-5Open DOISearch in Google Scholar
Iba T, Aihara K, Yamada A et al (2014) Rivaroxaban attenuates leukocyte adhesion in the microvasculature and thrombus formation in an experimental mouse model of type 2 diabetes mellitus. Thromb Res 133:276–280. doi: 10.1016/j.thromres.2013.11.013.IbaTAiharaKYamadaA2014Rivaroxaban attenuates leukocyte adhesion in the microvasculature and thrombus formation in an experimental mouse model of type 2 diabetes mellitus13327628010.1016/j.thromres.2013.11.013Open DOISearch in Google Scholar
Iwadate K, Doi M, Tanno K et al (2003) Right ventricular damage due to pulmonary embolism: examination of the number of infiltrating macrophages. Forensic Sci Int 134:147–153. doi: 10.1016/s0379-0738(03)00138-5IwadateKDoiMTannoK2003Right ventricular damage due to pulmonary embolism: examination of the number of infiltrating macrophages13414715310.1016/s0379-0738(03)00138-5Open DOISearch in Google Scholar
Jackson SP, Darbousset R, Schoenwaelder SM (2019) Thromboinflammation: challenges of therapeutically targeting coagulation and other host defense mechanisms. Blood 133:906–918. doi: 10.1182/blood-2018-11-882993JacksonSPDarboussetRSchoenwaelderSM2019Thromboinflammation: challenges of therapeutically targeting coagulation and other host defense mechanisms13390691810.1182/blood-2018-11-882993Open DOISearch in Google Scholar
Jezovnik MK, Poredos P (2010) Idiopathic venous thrombosis is related to systemic inflammatory response and to increased levels of circulating markers of endothelial dysfunction. Int Angiol 29:226–231.JezovnikMKPoredosP2010Idiopathic venous thrombosis is related to systemic inflammatory response and to increased levels of circulating markers of endothelial dysfunction29226231Search in Google Scholar
Jones AE, Watts JA, Debelak JP et al (2003) Inhibition of prostaglandin synthesis during polystyrene microsphere-induced pulmonary embolism in the rat. Am J Physiol Lung Cell Mol Physiol 284:L1072–1081. doi: 10.1152/ajplung.00283.2002JonesAEWattsJADebelakJP2003Inhibition of prostaglandin synthesis during polystyrene microsphere-induced pulmonary embolism in the rat284L1072108110.1152/ajplung.00283.2002Open DOISearch in Google Scholar
Joseph C, Berghausen EM, Behringer A et al (2022a) Coagulation-independent effects of thrombin and Factor Xa: role of protease-activated receptors in pulmonary hypertension. Cardiovasc Res 118:3225–3238. doi: 10.1093/cvr/cvac004JosephCBerghausenEMBehringerA2022aCoagulation-independent effects of thrombin and Factor Xa: role of protease-activated receptors in pulmonary hypertension1183225323810.1093/cvr/cvac004Open DOISearch in Google Scholar
Joseph P, Glynn R, Lonn E et al (2022b) Rosuvastatin for the prevention of venous thromboembolism: a pooled analysis of the HOPE-3 and JUPITER randomized controlled trials. Cardiovasc Res 118:897–903. doi: 10.1093/cvr/cvab078JosephPGlynnRLonnE2022bRosuvastatin for the prevention of venous thromboembolism: a pooled analysis of the HOPE-3 and JUPITER randomized controlled trials11889790310.1093/cvr/cvab078Open DOISearch in Google Scholar
Kapten K, Orczyk K, Smolewska E (2023) Immunity in SARS-CoV-2 Infection: Clarity or Mystery? A Broader Perspective in the Third Year of a Worldwide Pandemic. Arch Immunol Ther Exp 71:7. doi: 10.1007/s00005-023-00673-0KaptenKOrczykKSmolewskaE2023Immunity in SARS-CoV-2 Infection: Clarity or Mystery? A Broader Perspective in the Third Year of a Worldwide Pandemic71710.1007/s00005-023-00673-0Open DOISearch in Google Scholar
Klok FA, Ageno W, Ay C et al (2022) Optimal follow-up after acute pulmonary embolism: a position paper of the European Society of Cardiology Working Group on Pulmonary Circulation and Right Ventricular Function, in collaboration with the European Society of Cardiology Working Group on Atherosclerosis and Vascular Biology, endorsed by the European Respiratory Society. Eur Heart J 43:183–189. doi: 10.1093/eurheartj/ehab816KlokFAAgenoWAyC2022Optimal follow-up after acute pulmonary embolism: a position paper of the European Society of Cardiology Working Group on Pulmonary Circulation and Right Ventricular Function, in collaboration with the European Society of Cardiology Working Group on Atherosclerosis and Vascular Biology, endorsed by the European Respiratory Society4318318910.1093/eurheartj/ehab816Open DOISearch in Google Scholar
Konstantinides SV, Meyer G, Becattini C et al (2020) 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS). Eur Heart J 41:543–603. doi: 10.1093/eurheartj/ehz405KonstantinidesSVMeyerGBecattiniC20202019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS)4154360310.1093/eurheartj/ehz405Open DOISearch in Google Scholar
Konstantopoulos K, Neelamegham S, Burns AR et al (1998) Venous levels of shear support neutrophil-platelet adhesion and neutrophil aggregation in blood via P-selectin and beta2-integrin. Circulation 98:873–882. doi: 10.1161/01.cir.98.9.873KonstantopoulosKNeelameghamSBurnsAR1998Venous levels of shear support neutrophil-platelet adhesion and neutrophil aggregation in blood via P-selectin and beta2-integrin9887388210.1161/01.cir.98.9.873Open DOISearch in Google Scholar
Krata N, Foroncewicz B, Zagozdzon R et al (2021) Peroxiredoxins as markers of oxidative stress in IgA nephropathy, membranous nephropathy and lupus nephritis. Arch Immunol Ther Exp 70:3. doi: 10.1007/s00005-021-00638-1KrataNForoncewiczBZagozdzonR2021Peroxiredoxins as markers of oxidative stress in IgA nephropathy, membranous nephropathy and lupus nephritis70310.1007/s00005-021-00638-1Open DOISearch in Google Scholar
Kreit JW (2004) The impact of right ventricular dysfunction on the prognosis and therapy of normotensive patients with pulmonary embolism. Chest 125:1539–1545. doi: 10.1378/chest.125.4.1539KreitJW2004The impact of right ventricular dysfunction on the prognosis and therapy of normotensive patients with pulmonary embolism1251539154510.1378/chest.125.4.1539Open DOISearch in Google Scholar
Kunutsor SK, Seidu S, Khunti K (2017) Statins and primary prevention of venous thromboembolism: a systematic review and meta-analysis. Lancet Haematol 4:e83–e93. doi: 10.1016/S2352-3026(16)30184-3KunutsorSKSeiduSKhuntiK2017Statins and primary prevention of venous thromboembolism: a systematic review and meta-analysis4e83e9310.1016/S2352-3026(16)30184-3Open DOISearch in Google Scholar
Kurnicka K, Lichodziejewska B, Goliszek S et al (2016) Echocardiographic pattern of acute pulmonary embolism: Analysis of 511 consecutive patients. J Am Soc Echocardiogr 29:907–913. doi: 10.1016/j.echo.2016KurnickaKLichodziejewskaBGoliszekS2016Echocardiographic pattern of acute pulmonary embolism: Analysis of 511 consecutive patients2990791310.1016/j.echo.2016Open DOISearch in Google Scholar
Lacut K, Oger E, Abalain JH et al (2004) Effects of oral and transdermal 17 beta-estradiol combined with progesterone on homocysteine metabolism in postmenopausal women: a randomised placebo-controlled trial. Atherosclerosis 174:173–180. doi: 10.1016/j.atherosclerosis.2004.01.021LacutKOgerEAbalainJH2004Effects of oral and transdermal 17 beta-estradiol combined with progesterone on homocysteine metabolism in postmenopausal women: a randomised placebo-controlled trial17417318010.1016/j.atherosclerosis.2004.01.021Open DOISearch in Google Scholar
Laurent M, Joimel U, Varin R et al (2014) Comparative study of the effect of rivaroxaban and fondaparinux on monocyte's coagulant activity and cytokine release. Exp Hematol Oncol 3:30. doi: 10.1186/2162-3619-3-30LaurentMJoimelUVarinR2014Comparative study of the effect of rivaroxaban and fondaparinux on monocyte's coagulant activity and cytokine release33010.1186/2162-3619-3-30Open DOISearch in Google Scholar
Li CR, Wang LM, Gong Z et al (2015) Expression characteristics of neutrophil and mononuclear-phagocyte related genes mRNA in the stable angina pectoris and acute myocardial infarction stages of coronary artery disease. J Geriatr Cardiol 12:279–286. doi: 10.11909/j.issn.1671-5411.2015.03.021LiCRWangLMGongZ2015Expression characteristics of neutrophil and mononuclear-phagocyte related genes mRNA in the stable angina pectoris and acute myocardial infarction stages of coronary artery disease1227928610.11909/j.issn.1671-5411.2015.03.021Open DOISearch in Google Scholar
Li Y, Hook JS, Ding Q et al (2023) Neutrophil metabolomics in severe COVID-19 reveal GAPDH as a suppressor of neutrophil extra-cellular trap formation. Nat Commun 14:2610. doi: 10.1038/s41467-023-37567-wLiYHookJSDingQ2023Neutrophil metabolomics in severe COVID-19 reveal GAPDH as a suppressor of neutrophil extra-cellular trap formation14261010.1038/s41467-023-37567-wOpen DOISearch in Google Scholar
Ma Y, Zhang Y, Qiu C et al (2021) Rivaroxaban suppresses atherosclerosis by inhibiting FXa-induced macrophage M1 polarization-mediated phenotypic conversion of vascular smooth muscle cells. Front Cardiovasc Med 8:739212. doi: 10.3389/fcvm.2021.739212MaYZhangYQiuC2021Rivaroxaban suppresses atherosclerosis by inhibiting FXa-induced macrophage M1 polarization-mediated phenotypic conversion of vascular smooth muscle cells873921210.3389/fcvm.2021.739212Open DOISearch in Google Scholar
Martinez A, Oh HR, Unsworth EJ et al (2004) Matrix metalloproteinase-2 cleavage of adrenomedullin produces a vasoconstrictor out of a vasodilator. Biochem J 383(Pt 3):413–418. doi: 10.1042/BJ20040920MartinezAOhHRUnsworthEJ2004Matrix metalloproteinase-2 cleavage of adrenomedullin produces a vasoconstrictor out of a vasodilator383Pt 341341810.1042/BJ20040920Open DOISearch in Google Scholar
McConnell MV, Solomon SD, Rayan ME et al (1996) Regional right ventricular dysfunction detected by echocardiography in acute pulmonary embolism. Am J Cardiol 78:469–473. doi: 10.1016/s0002-9149(96)00339-6McConnellMVSolomonSDRayanME1996Regional right ventricular dysfunction detected by echocardiography in acute pulmonary embolism7846947310.1016/s0002-9149(96)00339-6Open DOISearch in Google Scholar
Mikolajczyk TP, Szczepaniak P, Vidler F et al (2021) Role of inflammatory chemokines in hypertension. Pharmacol Ther 223:107799. doi: 10.1016/j.pharmthera.2020.107799MikolajczykTPSzczepaniakPVidlerF2021Role of inflammatory chemokines in hypertension22310779910.1016/j.pharmthera.2020.107799Open DOISearch in Google Scholar
Neto-Neves EM, Dias-Junior CA, Uzuelli JA et al (2011) Sildenafil improves the beneficial hemodynamic effects exerted by atorvastatin during acute pulmonary thromboembolism. Eur J Pharmacol 670:554–560. doi: 10.1016/j.ejphar.2011.09.018Neto-NevesEMDias-JuniorCAUzuelliJA2011Sildenafil improves the beneficial hemodynamic effects exerted by atorvastatin during acute pulmonary thromboembolism67055456010.1016/j.ejphar.2011.09.018Open DOISearch in Google Scholar
Nishijima Y, Hader SN, Hanson AJ et al (2022) Prolonged endothelial-dysfunction in human arterioles following infection with SARS-CoV-2. Cardiovasc Res 118:18–19. doi: 10.1093/cvr/cvab339NishijimaYHaderSNHansonAJ2022Prolonged endothelial-dysfunction in human arterioles following infection with SARS-CoV-2118181910.1093/cvr/cvab339Open DOISearch in Google Scholar
Owens AP 3rd, Byrnes JR, Mackman N (2014) Hyperlipidemia, tissue factor, coagulation, and simvastatin. Trends Cardiovasc Med 24:95–98. doi: 10.1016/j.tcm.2013.07.003OwensAP3rdByrnesJRMackmanN2014Hyperlipidemia, tissue factor, coagulation, and simvastatin24959810.1016/j.tcm.2013.07.003Open DOISearch in Google Scholar
Patterson KA, Zhang X, Wrobleski SK et al (2013) Rosuvastatin reduced deep vein thrombosis in ApoE gene deleted mice with hyperlipidemia through non-lipid lowering effects. Thromb Res 131:268–276. doi: 10.1016/j.thromres.2012.12.006PattersonKAZhangXWrobleskiSK2013Rosuvastatin reduced deep vein thrombosis in ApoE gene deleted mice with hyperlipidemia through non-lipid lowering effects13126827610.1016/j.thromres.2012.12.006Open DOISearch in Google Scholar
Potere N, Garrad E, Kanthi Y et al (2023) NLRP3 inflammasome and interleukin-1 contributions to COVID-19-associated coagulopathy and immunothrombosis. Cardiovasc Res 119:2046–2060. doi: 10.1093/cvr/cvad084PotereNGarradEKanthiY2023NLRP3 inflammasome and interleukin-1 contributions to COVID-19-associated coagulopathy and immunothrombosis1192046206010.1093/cvr/cvad084Open DOISearch in Google Scholar
Pruszczyk P, Goliszek S, Lichodziejewska B et al (2014) Prognostic value of echocardiography in normotensive patients with acute pulmonary embolism. JACC Cardiovasc Imaging 7:553–560. doi: 10.1016/j.jcmg.2013.11.004PruszczykPGoliszekSLichodziejewskaB2014Prognostic value of echocardiography in normotensive patients with acute pulmonary embolism755356010.1016/j.jcmg.2013.11.004Open DOISearch in Google Scholar
Ramcharan AS, Van Stralen KJ, Snoep JD et al (2009) HMG-CoA reductase inhibitors, other lipid-lowering medication, antiplatelet therapy, and the risk of venous thrombosis. J Thromb Haemost 7:514–520. doi: 10.1111/j.1538-7836.2008.03235.xRamcharanASVan StralenKJSnoepJD2009HMG-CoA reductase inhibitors, other lipid-lowering medication, antiplatelet therapy, and the risk of venous thrombosis751452010.1111/j.1538-7836.2008.03235.xOpen DOISearch in Google Scholar
Ray JG, Mamdani M, Tsuyuki RT et al (2001) Use of statins and the subsequent development of deep vein thrombosis. Arch Intern Med 161:1405–1410. doi: 10.1001/archinte.161.11.1405RayJGMamdaniMTsuyukiRT2001Use of statins and the subsequent development of deep vein thrombosis1611405141010.1001/archinte.161.11.1405Open DOISearch in Google Scholar
Ribeiro A, Lindmarker P, Juhlin-Dannfelt A et al (1997) Echocardiography Doppler in pulmonary embolism: right ventricular dysfunction as a predictor of mortality rate. Am Heart J 134:479–487. doi: 10.1016/s0002-8703(97)70085-1RibeiroALindmarkerPJuhlin-DannfeltA1997Echocardiography Doppler in pulmonary embolism: right ventricular dysfunction as a predictor of mortality rate13447948710.1016/s0002-8703(97)70085-1Open DOISearch in Google Scholar
Ribeiro A, Lindmarker P, Johnsson H et al (1999) Pulmonary embolism: one-year follow-up with echocardiography doppler and five-year survival analysis. Circulation 99:1325–1330. doi: 10.1161/01.cir.99.10.1325RibeiroALindmarkerPJohnssonH1999Pulmonary embolism: one-year follow-up with echocardiography doppler and five-year survival analysis991325133010.1161/01.cir.99.10.1325Open DOISearch in Google Scholar
Rodriguez AL, Wojcik BM, Wrobleski SK et al. (2012) Statins, inflammation and deep vein thrombosis: a systematic review. J Thromb Thrombolysis 33:371–382. doi: 10.1007/s11239-012-0687-9RodriguezALWojcikBMWrobleskiSK2012Statins, inflammation and deep vein thrombosis: a systematic review3337138210.1007/s11239-012-0687-9Open DOISearch in Google Scholar
Rosenkranz AC, Schror K, Rauch BH (2011) Direct inhibitors of thrombin and factor Xa attenuate clot-induced mitogenesis and inflammatory gene expression in human vascular smooth muscle cells. Thromb Haemost 106:561–562. doi: 10.1160/TH11-04-0275RosenkranzACSchrorKRauchBH2011Direct inhibitors of thrombin and factor Xa attenuate clot-induced mitogenesis and inflammatory gene expression in human vascular smooth muscle cells10656156210.1160/TH11-04-0275Open DOISearch in Google Scholar
Sakr Y, M. Giovini M, Leone M et al (2020) Pulmonary embolism in patients with coronavirus disease-2019 (COVID-19) pneumonia: a narrative review. Ann Intensive Care 10:124. doi: 10.1186/s13613-020-00741-0SakrYM. GioviniMLeoneM2020Pulmonary embolism in patients with coronavirus disease-2019 (COVID-19) pneumonia: a narrative review1012410.1186/s13613-020-00741-0Open DOISearch in Google Scholar
Schoepf UJ, Kucher N, Kipfmueller F et al (2004) Right ventricular enlargement on chest computed tomography: a predictor of early death in acute pulmonary embolism. Circulation 110:3276–3280. doi: 10.1161/01.CIR.0000147612.59751.4CSchoepfUJKucherNKipfmuellerF2004Right ventricular enlargement on chest computed tomography: a predictor of early death in acute pulmonary embolism1103276328010.1161/01.CIR.0000147612.59751.4COpen DOISearch in Google Scholar
Shabanzadeh AP, Shuaib A, Wang CX (2005) Simvastatin reduced ischemic brain injury and perfusion deficits in an embolic model of stroke. Brain Res 1042:1–5. doi: 10.1016/j.brainres.2005.01.105ShabanzadehAPShuaibAWangCX2005Simvastatin reduced ischemic brain injury and perfusion deficits in an embolic model of stroke10421510.1016/j.brainres.2005.01.105Open DOISearch in Google Scholar
Sorensen HT, Horvath-Puho E, Pedersen L et al (2007) Venous thromboembolism and subsequent hospitalisation due to acute arterial cardiovascular events: a 20-year cohort study. Lancet 370:1773–1779. doi: 10.1016/S0140-6736(07)61745-0SorensenHTHorvath-PuhoEPedersenL2007Venous thromboembolism and subsequent hospitalisation due to acute arterial cardiovascular events: a 20-year cohort study3701773177910.1016/S0140-6736(07)61745-0Open DOISearch in Google Scholar
Sorensen HT, Horvath-Puho E, Sogaard KK et al (2009) Arterial cardiovascular events, statins, low-dose aspirin and subsequent risk of venous thromboembolism: a population-based case-control study. J Thromb Haemost 7:521–528. doi: 10.1111/j.1538-7836.2009.03279.xSorensenHTHorvath-PuhoESogaardKK2009Arterial cardiovascular events, statins, low-dose aspirin and subsequent risk of venous thromboembolism: a population-based case-control study752152810.1111/j.1538-7836.2009.03279.xOpen DOISearch in Google Scholar
Souza-Costa DC, T. Zerbini T, A. C. Palei AC et al (2005) L-arginine attenuates acute pulmonary embolism-induced increases in lung matrix metalloproteinase-2 and matrix metalloproteinase-9. Chest 128:3705–3710. doi: 10.1378/chest.128.5.3705Souza-CostaDCT. ZerbiniTA. C. PaleiAC2005L-arginine attenuates acute pulmonary embolism-induced increases in lung matrix metalloproteinase-2 and matrix metalloproteinase-91283705371010.1378/chest.128.5.3705Open DOISearch in Google Scholar
Souza-Costa DC, Figueiredo-Lopes L, Alves-Filho JC et al (2007) Protective effects of atorvastatin in rat models of acute pulmonary embolism: involvement of matrix metalloproteinase-9. Crit Care Med 35:239–245. doi: 10.1097/01.CCM.0000251638.67104.C3Souza-CostaDCFigueiredo-LopesLAlves-FilhoJC2007Protective effects of atorvastatin in rat models of acute pulmonary embolism: involvement of matrix metalloproteinase-93523924510.1097/01.CCM.0000251638.67104.C3Open DOISearch in Google Scholar
Springall R, Gonzalez-Flores J, Garcia-Avila C et al (2022) Elevated levels of soluble CD147 are associated with hyperinflammation and disease severity in COVID-19: A proof-of-concept clinical study. Arch Immunol Ther Exp 70:18. doi: 10.1007/s00005-022-00657-6SpringallRGonzalez-FloresJGarcia-AvilaC2022Elevated levels of soluble CD147 are associated with hyperinflammation and disease severity in COVID-19: A proof-of-concept clinical study701810.1007/s00005-022-00657-6Open DOISearch in Google Scholar
Squizzato A, Galli M, Romualdi E et al (2010) Statins, fibrates, and venous thromboembolism: a meta-analysis. Eur Heart J 31:1248–1256. doi: 10.1093/eurheartj/ehp556SquizzatoAGalliMRomualdiE2010Statins, fibrates, and venous thromboembolism: a meta-analysis311248125610.1093/eurheartj/ehp556Open DOISearch in Google Scholar
Sreejit G, Johnson J, Jaggers RM et al (2022) Neutrophils in cardiovascular disease: warmongers, peacemakers, or both? Cardiovasc Res 118:2596–2609. doi: 10.1093/cvr/cvab302SreejitGJohnsonJJaggersRM2022Neutrophils in cardiovascular disease: warmongers, peacemakers, or both?1182596260910.1093/cvr/cvab302Open DOISearch in Google Scholar
Sun TW, Zhang JY, Li L et al (2011) Effect atorvastatin on serum tumor necrosis factor alpha and interleukin-1beta following acute pulmonary embolism. Exp Lung Res 37:78–81. doi: 10.3109/01902148.2010.514647SunTWZhangJYLiL2011Effect atorvastatin on serum tumor necrosis factor alpha and interleukin-1beta following acute pulmonary embolism37788110.3109/01902148.2010.514647Open DOISearch in Google Scholar
Takahashi M (2022) NLRP3 inflammasome as a key driver of vascular disease. Cardiovasc Res 118:372–385. doi: 10.1093/cvr/cvab010TakahashiM2022NLRP3 inflammasome as a key driver of vascular disease11837238510.1093/cvr/cvab010Open DOISearch in Google Scholar
Tang Z, Wang X, Huang J et al (2016) Gene expression profiling of pulmonary artery in a rabbit model of pulmonary thromboembolism. PLoS One 11:e0164530. doi: 10.1371/journal.pone.0164530TangZWangXHuangJ2016Gene expression profiling of pulmonary artery in a rabbit model of pulmonary thromboembolism11e016453010.1371/journal.pone.0164530Open DOISearch in Google Scholar
Task Force for the management of COVID-19 of the European Society of Cardiology, Baigent C, Windecker S et al (2022) European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 1-epidemiology, pathophysiology, and diagnosis. Cardiovasc Res 118:1385–1412. doi: 10.1093/cvr/cvab342Task Force for the management of COVID-19 of the European Society of CardiologyBaigentCWindeckerS2022European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 1-epidemiology, pathophysiology, and diagnosis1181385141210.1093/cvr/cvab342Open DOISearch in Google Scholar
Tsang J, Simon M, Stewart K et al (2002) Proinflammatory cytokines are not released in the circulation following acute pulmonary thromboembolism in pigs. J Invest Surg 15:29–35. doi: 10.1080/08941930252807769TsangJSimonMStewartK2002Proinflammatory cytokines are not released in the circulation following acute pulmonary thromboembolism in pigs15293510.1080/08941930252807769Open DOISearch in Google Scholar
Veras FP, Gomes GF, Silva BMS et al (2023) Targeting neutrophils extracellular traps (NETs) reduces multiple organ injury in a COVID-19 mouse model. Respir Res 24:66. doi: 10.1186/s12931-023-02336-2VerasFPGomesGFSilvaBMS2023Targeting neutrophils extracellular traps (NETs) reduces multiple organ injury in a COVID-19 mouse model246610.1186/s12931-023-02336-2Open DOISearch in Google Scholar
Wakefield TW, Strieter RM, Wilke CA et al (1995) Venous thrombosis-associated inflammation and attenuation with neutralizing antibodies to cytokines and adhesion molecules. Arterioscler Thromb Vasc Biol 15:258–268. doi: 10.1161/01.atv.15.2.258WakefieldTWStrieterRMWilkeCA1995Venous thrombosis-associated inflammation and attenuation with neutralizing antibodies to cytokines and adhesion molecules1525826810.1161/01.atv.15.2.258Open DOISearch in Google Scholar
Wakefield TW, Strieter RM, Downing LJ et al (1996) P-selectin and TNF inhibition reduce venous thrombosis inflammation. J Surg Res 64:26–31. doi: 10.1006/jsre.1996.0301WakefieldTWStrieterRMDowningLJ1996P-selectin and TNF inhibition reduce venous thrombosis inflammation64263110.1006/jsre.1996.0301Open DOISearch in Google Scholar
Walcheck B, Moore KL, McEver RP et al (1996) Neutrophil-neutrophil interactions under hydrodynamic shear stress involve L-selectin and PSGL-1. A mechanism that amplifies initial leukocyte accumulation of P-selectin in vitro. J Clin Invest 98:1081–1087. doi: 10.1172/JCI118888WalcheckBMooreKLMcEverRP1996Neutrophil-neutrophil interactions under hydrodynamic shear stress involve L-selectin and PSGL-1. A mechanism that amplifies initial leukocyte accumulation of P-selectin in vitro981081108710.1172/JCI118888Open DOISearch in Google Scholar
Wang Y, Yu D, Yu Y et al (2020) Association Between inflammatory mediators and pulmonary blood flow in a rabbit model of acute pulmonary embolism combined with shock. Front Physiol 11:1051. doi: 10.3389/fphys.2020.01051WangYYuDYuY2020Association Between inflammatory mediators and pulmonary blood flow in a rabbit model of acute pulmonary embolism combined with shock11105110.3389/fphys.2020.01051Open DOISearch in Google Scholar
Watts JA, Zagorski J, Gellar MA et al (2006) Cardiac inflammation contributes to right ventricular dysfunction following experimental pulmonary embolism in rats. J Mol Cell Cardiol 41:296–307. doi: 10.1016/j.yjmcc.2006.05.011WattsJAZagorskiJGellarMA2006Cardiac inflammation contributes to right ventricular dysfunction following experimental pulmonary embolism in rats4129630710.1016/j.yjmcc.2006.05.011Open DOISearch in Google Scholar
Watts JA, Gellar MA, Obraztsova M et al (2008) Role of inflammation in right ventricular damage and repair following experimental pulmonary embolism in rats. Int J Exp Pathol 89:389–399. doi: 10.1111/j.1365-2613.2008.00610.xWattsJAGellarMAObraztsovaM2008Role of inflammation in right ventricular damage and repair following experimental pulmonary embolism in rats8938939910.1111/j.1365-2613.2008.00610.xOpen DOISearch in Google Scholar
Wood KE (2002) Major pulmonary embolism: review of a pathophysiologic approach to the golden hour of hemodynamically significant pulmonary embolism. Chest 121:877–905. doi: 10.1378/chest.121.3.877WoodKE2002Major pulmonary embolism: review of a pathophysiologic approach to the golden hour of hemodynamically significant pulmonary embolism12187790510.1378/chest.121.3.877Open DOISearch in Google Scholar
Zagorski J, Debelak J, Gellar M et al (2003) Chemokines accumulate in the lungs of rats with severe pulmonary embolism induced by polystyrene microspheres. J Immunol 171:5529–5536. doi: 10.4049/jimmunol.171.10.5529ZagorskiJDebelakJGellarM2003Chemokines accumulate in the lungs of rats with severe pulmonary embolism induced by polystyrene microspheres1715529553610.4049/jimmunol.171.10.5529Open DOISearch in Google Scholar
Zagorski J, Gellar MA, Obraztsova M et al (2007) Inhibition of CINC-1 decreases right ventricular damage caused by experimental pulmonary embolism in rats. J Immunol 179:7820–7826. doi: 10.4049/jimmunol.179.11.7820ZagorskiJGellarMAObraztsovaM2007Inhibition of CINC-1 decreases right ventricular damage caused by experimental pulmonary embolism in rats1797820782610.4049/jimmunol.179.11.7820Open DOISearch in Google Scholar
Zagorski J, Sanapareddy N, Gellar MA et al (2008) Transcriptional profile of right ventricular tissue during acute pulmonary embolism in rats. Physiol Genomics 34:101–111. doi: 10.1152/physiolgenomics.00261.2007ZagorskiJSanapareddyNGellarMA2008Transcriptional profile of right ventricular tissue during acute pulmonary embolism in rats3410111110.1152/physiolgenomics.00261.2007Open DOISearch in Google Scholar
Zagorski J, Obraztsova M, Gellar MA et al (2009) Transcriptional changes in right ventricular tissues are enriched in the out-flow tract compared with the apex during chronic pulmonary embolism in rats. Physiol Genomics 39:61–71. doi: 10.1152/physiolgenomics.00076.2009ZagorskiJObraztsovaMGellarMA2009Transcriptional changes in right ventricular tissues are enriched in the out-flow tract compared with the apex during chronic pulmonary embolism in rats39617110.1152/physiolgenomics.00076.2009Open DOISearch in Google Scholar
Zagorski J, Kline JA (2016) Differential effect of mild and severe pulmonary embolism on the rat lung transcriptome. Respir Res 17:86. doi: 10.1186/s12931-016-0405-9ZagorskiJKlineJA2016Differential effect of mild and severe pulmonary embolism on the rat lung transcriptome178610.1186/s12931-016-0405-9Open DOISearch in Google Scholar
Zhao YD, Yun HZH, Peng J et al (2014) De novo synthesize of bile acids in pulmonary arterial hypertension lung. Metabolomics 10:1169–1175. doi: 10.1007/s11306-014-0653-yZhaoYDYunHZHPengJ2014De novo synthesize of bile acids in pulmonary arterial hypertension lung101169117510.1007/s11306-014-0653-yOpen DOISearch in Google Scholar
Zhou Q, Bea F, Preusch M et al (2011) Evaluation of plaque stability of advanced atherosclerotic lesions in apo E-deficient mice after treatment with the oral factor Xa inhibitor rivaroxaban. Mediators Inflamm 2011:432080. doi: 10.1155/2011/432080ZhouQBeaFPreuschM2011Evaluation of plaque stability of advanced atherosclerotic lesions in apo E-deficient mice after treatment with the oral factor Xa inhibitor rivaroxaban201143208010.1155/2011/432080Open DOISearch in Google Scholar